Dr. Fausel on the Evolution of Genomic Testing in Cancer Care

Christopher A. Fausel, PharmD, MHA, BCOP, clinical manager, Oncology Pharmacy, Indiana University, Melvin and Bren Simon Comprehensive Cancer Center, health chairman, Board of Hoosier Cancer Research Network, discusses how genetic sequencing has played a growing role in cancer care.

Cancer care has continued evolve in recent years, including the emergence of targeted therapy, which have revolutionized treatment for different types of solid tumor and hematologic malignancies, Fausel says. Additionally, genomic sequencing has become a viable option due to improved cost and time, Fausel adds.

When a patient has failed to respond or has stopped responding to treatment, genomic sequencing can any actionable mutations that can inform other treatment options, Fausel concludes.